Li Ting, Yan Jingxin, Ren Qiuyu, Hu Jiang, Wang Fei, Xiao Chengwei, Liu Xilin
Department of Orthopedics, Sichuan Provincial People's Hospital, Chengdu, China.
Department of Postgraduate, Chengdu Medical College, Chengdu, China.
Front Surg. 2023 Jan 6;9:1005200. doi: 10.3389/fsurg.2022.1005200. eCollection 2022.
This systematic review and meta-analysis was performed to summarize available evidence of anterior transposition of the ulnar nerve for patients with distal humerus fractures.
The databases were searched from PubMed, Cochrane, Embase, Scopus, Web of Science, Chinese National Knowledge Infrastructure (CNKI), Chongqing VIP Database (VIP), and Wan Fang Database up to June 2022. The clinical outcome included operation time, fracture healing time, hospital stays, elbow joint function, and ulnar neuritis rate. Statistical analysis was performed with Review Manager 5.3 (Cochrane Collaboration).
A total of 17 studies were included (8 RCTs and 9 retrospective studies), and 1280 patients were analyzed. The results of this meta-analysis showed anterior transposition group had longer operation time (MD = 20.35 min, 95%CI: 12.56-28.14, < 0.00001). There was no significant difference in fracture healing time (SMD = -0.50, 95%CI: -1.50-0.50, = 0.33), hospital stays (MD = -1.23 days, 95%CI: -2.72--0.27, = 0.11), blood loss (MD = 2.66 ml, 95%CI: -2.45-7.76, = 0.31), and ulnar neuritis rate (OR = 1.23, 95%CI: 0.63-2.42, = 0.54) between two groups. Finally, elbow joint motion, elbow joint function, fracture nonunion, and post-operative infection ( > 0.05) between two groups were not significantly statistic difference.
This meta-analysis showed that anterior transposition group is not superior to non-transposition group for patients with distal humerus fractures without ulnar nerve injury. On the contrary, non-transposition group have shorter operation time than that of anterior transposition group. Non-transposition group did not increase the post-operative ulnar neuritis rate. Therefore, both anterior transposition group and non- transposition group are the treatment options for patients with distal humerus fractures without ulnar nerve injury. Besides, these findings need to be further verified by multi-center, double-blind, and large sample RCTs.
本系统评价和荟萃分析旨在总结肱骨远端骨折患者尺神经前置术的现有证据。
检索截至2022年6月的PubMed、Cochrane、Embase、Scopus、Web of Science、中国知网(CNKI)、重庆维普数据库(VIP)和万方数据库。临床结局包括手术时间、骨折愈合时间、住院时间、肘关节功能和尺神经炎发生率。使用Review Manager 5.3(Cochrane协作网)进行统计分析。
共纳入17项研究(8项随机对照试验和9项回顾性研究),分析了1280例患者。该荟萃分析结果显示,尺神经前置组手术时间更长(MD = 20.35分钟,95%CI:12.56 - 28.14,P < 0.00001)。两组在骨折愈合时间(SMD = -0.50,95%CI:-1.50 - 0.50,P = 0.33)、住院时间(MD = -1.23天,95%CI:-2.72 - -0.27,P = 0.11)、失血量(MD = 2.66毫升,95%CI:-2.45 - 7.76,P = 0.31)和尺神经炎发生率(OR = 1.23,95%CI:0.63 - 2.42,P = 0.54)方面无显著差异。最后,两组之间的肘关节活动度、肘关节功能、骨折不愈合和术后感染(P > 0.05)无显著统计学差异。
该荟萃分析表明,对于无尺神经损伤的肱骨远端骨折患者,尺神经前置组并不优于非前置组。相反,非前置组手术时间比尺神经前置组短。非前置组并未增加术后尺神经炎发生率。因此,尺神经前置组和非前置组都是无尺神经损伤的肱骨远端骨折患者的治疗选择。此外,这些研究结果需要通过多中心、双盲和大样本随机对照试验进一步验证。